Molina Healthcare (MOH) Q3 2026 Earnings Call Transcript
Molina Healthcare (MOH) reported Q3 2026 adjusted EPS of $0.89B on $10.5B premium revenue, with a 92.9% MCR. Full-year 2026 guidance remains $42B in premium revenue and at least $5.25 EPS. 2027 premium revenue is expected to be at least $45B, with known rate increases averaging 6% and medical cost trend projected at 5.5%-6%. The company reaffirmed its Medicaid and Medicare strategies, including exiting the MAPD business and reducing Marketplace footprint.
How this was made

The 30-second read
Why it matters
The reaffirmed guidance and detailed Medicaid rate outlook give traders fresh data to price the stock.
Market read
First report of Q3 results and FY guidance provides actionable insight for traders.
What to watch
Potential upside from delayed Medicaid contracts in GA and TX if resolved earlier than anticipated.
Background
Molina Healthcare provided its Q3 earnings call transcript, reaffirming full-year guidance and outlining 2027 outlook.
Ticker impact
Q3 2026 earnings call disclosed adjusted EPS of $0.89B, $10.5B premium revenue and reaffirmed FY 2026 guidance of $42B revenue and $5.25 EPS.
likely slight downside as market prices in unchanged guidance amid cost concerns
Earnings and guidance are primary disclosures; investors may react conservatively.
Market effects
Healthcare insurance sector may see modest pressure as Molina's guidance suggests stable but not accelerating growth.
U.S. market participants focused on Medicaid and Medicare trends may adjust expectations for similar insurers.
Limited global impact; primarily relevant to U.S. health insurance investors.
Counterpoint
If Medicaid rate increases exceed expectations, the stock could rally on upside margin potential.
Key entities
- CompanyMolina Healthcare
U.S.-listed health insurer (ticker MOH).
- ExecutiveJoe Zubretsky
CEO of Molina Healthcare delivering the earnings call.


